140 related articles for article (PubMed ID: 22419026)
1. Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma.
Lauriola L; Granone P; Ramella S; Lanza P; Ranelletti FO
Histol Histopathol; 2012 May; 27(5):617-26. PubMed ID: 22419026
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
[TBL] [Abstract][Full Text] [Related]
3. Hu/elav RNA-binding protein HuR regulates parathyroid hormone related peptide expression in human lung adenocarcinoma cells.
Lauriola L; Serini S; Granone P; Lanza P; Martini M; Calviello G; Ranelletti FO
Histol Histopathol; 2013 Sep; 28(9):1205-16. PubMed ID: 23572284
[TBL] [Abstract][Full Text] [Related]
4. Expression of HuR, COX-2, and survivin in lung cancers; cytoplasmic HuR stabilizes cyclooxygenase-2 in squamous cell carcinomas.
Kim GY; Lim SJ; Kim YW
Mod Pathol; 2011 Oct; 24(10):1336-47. PubMed ID: 21572400
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma.
Zhang C; Xue G; Bi J; Geng M; Chu H; Guan Y; Wang J; Wang B
Tumour Biol; 2014 Jan; 35(1):73-80. PubMed ID: 23873103
[TBL] [Abstract][Full Text] [Related]
6. Hu-antigen receptor (HuR) and cyclooxygenase-2 (COX-2) expression in human non-small-cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival.
Giaginis C; Alexandrou P; Tsoukalas N; Sfiniadakis I; Kavantzas N; Agapitos E; Patsouris E; Theocharis S
Tumour Biol; 2015 Jan; 36(1):315-27. PubMed ID: 25252849
[TBL] [Abstract][Full Text] [Related]
7. The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.
Wang J; Zhao W; Guo Y; Zhang B; Xie Q; Xiang D; Gao J; Wang B; Chen Z
Oncology; 2009; 76(6):420-9. PubMed ID: 19420963
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer.
Wang J; Wang B; Bi J; Zhang C
Med Oncol; 2011 Dec; 28 Suppl 1():S577-85. PubMed ID: 21046284
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
[TBL] [Abstract][Full Text] [Related]
10. MiR-200c and HuR in ovarian cancer.
Prislei S; Martinelli E; Mariani M; Raspaglio G; Sieber S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
BMC Cancer; 2013 Feb; 13():72. PubMed ID: 23394580
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.
Wang J; Li D; Wang B; Wu Y
Breast Cancer Res Treat; 2013 Sep; 141(2):213-24. PubMed ID: 24036660
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression.
Denkert C; Weichert W; Pest S; Koch I; Licht D; Köbel M; Reles A; Sehouli J; Dietel M; Hauptmann S
Cancer Res; 2004 Jan; 64(1):189-95. PubMed ID: 14729623
[TBL] [Abstract][Full Text] [Related]
13. Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.
Antonângelo L; Tuma T; Fabro A; Acencio M; Terra R; Parra E; Vargas F; Takagaki T; Capelozzi V
Exp Biol Med (Maywood); 2016 Jun; 241(11):1159-68. PubMed ID: 26869608
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.
Zhu Z; Wang B; Bi J; Zhang C; Guo Y; Chu H; Liang X; Zhong C; Wang J
Tumour Biol; 2013 Aug; 34(4):2299-308. PubMed ID: 23605320
[TBL] [Abstract][Full Text] [Related]
15. Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.
Denkert C; Koch I; von Keyserlingk N; Noske A; Niesporek S; Dietel M; Weichert W
Mod Pathol; 2006 Sep; 19(9):1261-9. PubMed ID: 16799479
[TBL] [Abstract][Full Text] [Related]
16. HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma.
Liang PI; Li WM; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Wei YC; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Lin CM; Li CF
BMC Cancer; 2012 Dec; 12():611. PubMed ID: 23259573
[TBL] [Abstract][Full Text] [Related]
17. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
[TBL] [Abstract][Full Text] [Related]
18. Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival.
Frey A; Soubani AO; Adam AK; Sheng S; Pass HI; Lonardo F
Histopathology; 2009 Apr; 54(5):590-7. PubMed ID: 19309490
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.
Takagi Y; Matsuoka Y; Shiomi T; Nosaka K; Takeda C; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Histopathology; 2015 Apr; 66(5):732-9. PubMed ID: 25322663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
